Aurobindo Pharma Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1501 as of 18 May 15:30 . The P/E Ratio of Aurobindo Pharma Ltd changed from 9.7 on March 2021 to 19.3 on March 2025 . This represents a CAGR of 14.75% over 5 yearsThe P/E Ratio of Shree Ganesh Remedies Ltd changed from 30.5 on March 2024 to 39.6 on March 2025 . This represents a CAGR of 13.95% over 2 years The Market Cap of Aurobindo Pharma Ltd changed from ₹ 51653 crore on March 2021 to ₹ 67951 crore on March 2025 . This represents a CAGR of 5.64% over 5 yearsThe Market Cap of Shree Ganesh Remedies Ltd changed from ₹ 801.21 crore on March 2024 to ₹ 913.01 crore on March 2025 . This represents a CAGR of 6.75% over 2 years The revenue of Aurobindo Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 8833 crore. This represent the decline of -100% The revenue of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 34.22 crore as compare to the Dec '25 revenue of ₹ 21.76 crore. This represent the growth of 57.26% The ebitda of Aurobindo Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 1896 crore. This represent the decline of -100% The ebitda of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 12.4 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the growth of 67.79% The net profit of Aurobindo Pharma Ltd changed from ₹ 918.22 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 4.65 crore to ₹ 6.27 crore over 8 quarters. This represents a CAGR of 16.12% The Dividend Payout of Aurobindo Pharma Ltd changed from 7.53 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in December 1986 as a private limited company.
Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
APL is running with 29 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

FAQs for the comparison of Aurobindo Pharma Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Shree Ganesh Remedies Ltd?

Market cap of Aurobindo Pharma Ltd is 87,776 Cr while Market cap of Shree Ganesh Remedies Ltd is 738 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Aurobindo Pharma Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Shree Ganesh Remedies Ltd?

As of May 18, 2026, the Aurobindo Pharma Ltd stock price is INR ₹1511.3. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹575.6.

How do dividend payouts of Aurobindo Pharma Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.